Ads
related to: moderna vaccine
Search results
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 1 day agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 7 days ago"Although regulatory delays are disappointing and usually create noise around the probability of...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 5 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 4 days agoThis analysis aims to determine whether Moderna's stock is significantly overvalued by examining its current market performance and intrinsic value. Founded in 2010 and going ...
Quick takes: Moderna's RSV vaccine, flu-COVID combo vaccines, new polio cases
Center for Infectious Disease Research and Policy· 6 days agoThe FDA has pushed back its review of Moderna's RSV vaccine owing to administrative issues.
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 4 days agoFortunately, there are good reasons to believe the company has what it takes. Moderna is inching...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 5 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...